Cupid Limited , a prominent Indian healthcare and diagnostics manufacturer, has achieved a significant milestone in its global expansion strategy. The company recently announced that it has received CE (EU IVDR) Certification for two of its key in-vitro diagnostic (IVD) devices: the CupiSURE Pregnancy (hCG) Test Kit and the CupiKIT Syphilis Antibody Test Kit.

Certification Details and Market Impact

The CE certification, which confirms compliance with the European Union Regulation (EU) 2017/746 (IVDR), allows Cupid Limited to distribute these kits across the European Economic Area and other CE-recognized global markets. This development marks a crucial step in Cupid's transition from an Indian healthcare exporter to a globally certified IVD solutions provider.

Market Opportunities

The certification positions Cupid Limited to tap into rapidly growing diagnostic markets:

Future Certifications and Market Expansion

Cupid Limited is also in the final stages of securing CE (EU IVDR) Certification for its HIV 1 & 2 Antibody and Hepatitis B Antigen IVD kits, expected by December 2025. These additional certifications will further expand the company's reach in the global IVD market:

Strategic Implications

The CE certifications enable Cupid Limited to:

1. Participate in European, African, and Latin American tenders for maternal health, STD, and infectious-disease screening.
2. Leverage its low-cost, high-quality manufacturing base in India to offer competitively priced global IVD solutions.
3. Diversify beyond sexual-health products into the broader preventive and diagnostic healthcare space.

Management Commentary

Aditya Kumar Halwasiya, Chairman and Managing Director of Cupid Limited, stated, "The CE (EU IVDR) Certification for our Pregnancy and Syphilis Antibody IVD kits is a milestone achievement that validates Cupid's global quality standards and technical excellence. These certifications open up huge opportunities for us across Europe, Africa, and Asia."

Company Background

Established in 1993, Cupid Limited has evolved from being India's premier manufacturer of male and female condoms to a diversified healthcare company. The company has expanded its product portfolio to include water-based personal lubricants, IVD kits, and various FMCG products. Cupid Limited exports to over 110 countries and has a long-term agreement with WHO / UNFPA.

This certification marks a significant step in Cupid Limited's journey towards becoming a global player in the IVD market, potentially opening doors to new revenue streams and market opportunities across multiple continents.

Cupid Limited , a leading Indian manufacturer and exporter of healthcare and wellness products, has been honored at the Maharashtra State Export Award Ceremony. The prestigious event, held on October 13 at Taj Lands End, Mumbai, recognized top-performing exporters for their significant contributions to Maharashtra's global trade leadership.

Award Recognition

The Government of Maharashtra organized this ceremony to acknowledge companies that have demonstrated exceptional export performance. Cupid Limited's recognition at this event underscores its robust growth and consistent excellence in international markets across Africa, Latin America, Asia, Europe, and the Middle East.

Company Performance and Global Reach

Cupid Limited has established itself as a trusted brand in the global healthcare and wellness segment. The company currently exports its products to over 110 countries, with a substantial portion of its revenue generated from international markets. Notably, Cupid is the first company worldwide to achieve WHO/UNFPA pre-qualification for both male and female condoms.

Strategic Expansion

In line with its growth strategy, Cupid Limited has recently expanded its product portfolio to include various Fast-Moving Consumer Goods (FMCG). The company's product range now encompasses:

• Male and female condoms
• Water-based personal lubricants
• IVD kits
• Fragrance products (Eau De Perfumes, Deodorants, Pocket Perfumes)
• Personal care items (Toilet Sanitizers, Hair & Body Oils, Hair Removal Sprays, Face Wash)
• Other wellness solutions

Production Capacity Enhancement

To support its growth trajectory, Cupid Limited completed a strategic land acquisition in Palava, Maharashtra, in March 2024. This move is set to significantly boost the company's production capacity:

This expansion represents a 1.5-fold increase in the company's existing output.

Management's Perspective

Mr. Aditya Kumar Halwasiya, Chairman and Managing Director of Cupid Limited, expressed his thoughts on receiving the award: "We are deeply honored to receive this recognition from the Government of Maharashtra. This award is a testament to our team's commitment to quality, innovation, and purpose-driven growth. Cupid's success in exports reflects not only our product excellence but also India's growing reputation as a trusted manufacturing hub for health and wellness solutions worldwide."

The Maharashtra State Export Award serves as a reaffirmation of Cupid Limited's continued focus on expanding its international footprint while contributing meaningfully to India's export growth and sustainable development goals. As the company continues to innovate and expand its product range, it remains well-positioned to capitalize on global market opportunities in the healthcare and wellness sector.